EMEA-001908-PIP01-15

  • Email
  • Help

Overview

Product details for P/0114/2016
Invented nameP/0114/2016
Active substance

Montelukast (sodium) / levocetirizine (dihydrochloride)

Decision numberP/0114/2016
PIP numberEMEA-001908-PIP01-15
Pharmaceutical form(s)Film-coated tablet
Condition(s)/indication(s)

Treatment of asthma

Route(s) of administrationOral use
PIP applicant

Invest Bielany Sp. z o.o.
Poland
Tel. +48 734666650
Fax +48 228411671
E-mail: katarzyna.rawa@investbielany.pl

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision